🔍
Hybridoma (MY-31)
Case ID:
C09194
Report of Invention:
1/1/1985
Web Published:
12/19/2016
TITLE Hybridoma (MY-31)
CASE NUMBER C09194
DESCRIPTION
CD56, clone MY31, is derived by immunizing (C57BL/6 x BALB/c) F1 mice with the KG1a cell line and fusing the immune splenocytes with the SP2/0 myeloma cell line.
CD56 recognizes an antigen present on natural killer (NK) lymphocytes.
PUBLICATION
Lanier, L.L., Le, A.M., Civin, C.I., Loken, M.R., Phillips, J.H. The Relationship of CD16 (Leu 11) and Leu 19 (NKH–1) Antigen Expression on Human Peripheral Blood NK Cells and Cytotoxic T Lymphocytes. J Immunol 136:4480–4486, 1986
Patent Information:
Title
App Type
Country
Serial No.
Patent No.
File Date
Issued Date
Expire Date
Patent Status
Direct Link:
https://jhu.technologypublisher.com/technology/23713
Inventors:
Category(s):
Technology Classifications > Research Tools > Antibodies, Technology Classifications > Research Tools > Cell Lines, Technology Classifications > Research Tools,
Get custom alerts for techs in these categories/from these inventors:
Subscribe for JHTV Updates
For Information, Contact:
Sahil Aggarwal
sahil.aggarwal@jhu.edu
410-614-0300
Save This Technology:
Bookmark this page
Download as PDF
JHTV Home
|
Search
|
Login/Subscribe
2017 - 2022 © Johns Hopkins Technology Ventures. All Rights Reserved. Powered by
Inteum